Chapter 2

More documents

Recommendations

Info

2004. Bisogni, risorse e nuove strategie”, Italpromo Esis Publishing. ● Atella V, Donia Sofio A, Meneguzzo M, Mennini FS, Spandonaro F (edited by) 2005, “Rapporto CEIS Sanità 2004. Bisogni, risorse e nuove strategie”, Italpromo Esis Publishing. ● Colombo F e Mennini FS (2004). “Evoluzione della Spesa Sanitaria nei Paesi OCSE”, in Rapporto CEIS Sanità 2004. Bisogni, risorse e nuove strategie, edited by Atella V, Donia Sofio A, Mennini FS, Spandonaro F, Italpromo Esis Publishing, Roma, 2004. ● Colombo F, Tapay N (2004). “Private Health Insurance in OECD Countries. The Benefits and Costs for Individuals and Health Systems”. OECD Health Working Papers, No. 15. Paris: OECD (Available at www.oecd.org/health). ● Docteur E, Oxley H (2003). “Health Care Systems: Lessons from the Reform Experience”. OECD Health Working Papers, No. 9. Paris: OECD (Available at www.oecd.org/health). ● Docteur E, Suppanz H, Woo J (2003). “The U.S. Health System: An Assessment and Prospective Directions for Reform. OECD Economics Department Working Paper No. 350. Paris: OECD. (Available at www.oecd.org/health). ● Dutch Ministry of Health, Welfare and Sport (2002). “A Question of Demand. Outlines of the reform of the health care system in the Netherlands”. The Hague: Ministry of Health, Welfare and Sport. ● Huber M, Orosz E (2003). “Health Expenditure Trends in OECD Countries, 1990-2001”. Health Care Financing Review, Vol. 25, No. 1, pp 1-22 Fall 2003. ● Hurst J, Siciliani L (2003). “Tackling Excessive Waiting Times for Elective Surgery: A Comparison of Policies in Twelve OECD Countries”. OECD Health Working Papers, No.6. Paris: OECD (Available at www.oecd.org/health). ● Jacobzone S (2000). “Pharmaceutical Policies in OECD Countries: Reconciling Social and Industrial Goals”. OECD Labour Market and Social Policy Occasional Paper, N. 40. Paris: OECD. ● Maynard A (2005). “European Health Policy Challenges”, Health Economics, Vol. 14, N. S1, September 2005. ● McClellan M, Every N, Garber A, Heidenreich P, Hlatky M, Kessler D, Newhouse JP, Saynina O (2002), “Technological Change in Heart Attack Care in the United States: Causes and Consequences” in McClellan M and Kessler D (eds.), Technological Change in Health Care: A Global Analysis of Heart Attack. University of Michigan Press, pp. 21-54. ● Mennini e Francia, “Il quadro macroeconomico ed istituzionale e l’evoluzione della spesa sanitaria in Italia e nell’UE”, in Rapporto CEIS Sanità 2003. Bisogni, risorse e nuove strategie, edited by Atella V, Donia Sofio A, Mennini FS, Spandonaro F, Italpromo Esis Publishing, Roma, 2003. ● Mennini e Francia, “Evoluzione della spesa sanitaria nei Paesi OCSE”, in Rapporto CEIS Sanità 2005, edited by Atella V, Donia Sofio A, Meneguzzo M, Mennini FS, Spandonaro F, Italpromo Esis Publishing, Roma, 2005. ● Mossialos E, Le Grand J (1999). “Cost containment in the EU: an overview”. In Mossialos E, Le Grand J (eds), Health Care and Cost Containment in the European Union. Ashgate, Aldershot. ● OECD (2006). “OECD Health Data 2006, Giugno 2006”. CD-ROM and user manual. Paris: OECD (www.oecd.org/health/healthdata). [55] CEIS Health Report 2006
CEIS Health Report 2006 ● OECD (2004b). “Towards High-Performing Health Systems”. Paris: OECD. ● OECD (2004c, forthcoming). “Private Health Insurance in OECD Countries”. Paris: OECD. ● OECD (2003a). “OECD Reviews of Health Care Systems: Korea”. Paris: OECD. ● OECD (2003b). “Health at a Glance, 2nd Edition. OECD Indicators 2003”. Paris: OECD. ● Oliver A, Mossialos E, Maynard A (2005), “The contestable nature of health policy analysis”, Health Economics, Vol. 14, Num. S1, September 2005. ● Reinhardt UE, Hussey PS, Anderson GF (2004). “U.S. Health Care Spending In An International Context”. Health Affairs, May/June 2004, Vol. 23, N. 33, pp. 10-25. ● Reinhardt UE, Hussey PS, Anderson GF (2004). “Cross-National Comparison Of Health Systems Using OECD Data, 1999”. Health Affairs, May/June 2002, Vol. 21, N. 3, pp. 169-181. [56]
Page 1 and 2:
CEIS Health Report 2006 Management
Page 3 and 4: CEIS Health Report 2006 Management
Page 6 and 7: Index Report Presentation by Pagane
Page 8 and 9: 1.6 - The Regional Primary Care Agr
Page 10 and 11: Chapter 3 - Efficiency 3.1 - The Ef
Page 12 and 13: 3.8 - Private Health Insurance and
Page 14: Ceis - Sanità Report presentation
Page 17 and 18: Warning The figures in the volume f
Page 19 and 20: CEIS Health Report 2006 stantial, i
Page 21 and 22: CEIS Health Report 2006 If, therefo
Page 23 and 24: CEIS Health Report 2006 Cross-check
Page 25 and 26: CEIS Health Report 2006 over € 6.
Page 27 and 28: CEIS Health Report 2006 made; final
Page 29 and 30: CEIS Health Report 2006 Although th
Page 31 and 32: CEIS Health Report 2006 Aside from
Page 33 and 34: CEIS Health Report 2006 Regulations
Page 35 and 36: CEIS Health Report 2006 especially
Page 38: Chapter 1 Health expenditure and fu
Page 41 and 42: CEIS Health Report 2006 The questio
Page 43 and 44: CEIS Health Report 2006 Table 1 - T
Page 45 and 46: CEIS Health Report 2006 Figure 3 -
Page 53: CEIS Health Report 2006 ciated with
Page 59 and 60: CEIS Health Report 2006 the phenome
Page 61 and 62: CEIS Health Report 2006 Table 3 - R
Page 63 and 64: CEIS Health Report 2006 The indicat
Page 65 and 66: CEIS Health Report 2006 References
Page 67 and 68: CEIS Health Report 2006 All the var
Page 69 and 70: CEIS Health Report 2006 Diagram 1 -
Page 71 and 72: CEIS Health Report 2006 1.4 - Pharm
Page 73 and 74: CEIS Health Report 2006 % Pharmaceu
Page 75 and 76: CEIS Health Report 2006 The second
Page 77 and 78: CEIS Health Report 2006 tion of res
Page 79 and 80: CEIS Health Report 2006 Table 4 - R
Page 81 and 82: CEIS Health Report 2006 The variati
Page 83 and 84: CEIS Health Report 2006 1.5 - The r
Page 87 and 88: CEIS Health Report 2006 southern Re
Page 89 and 90: CEIS Health Report 2006 1.5.5 Absor
Page 91 and 92: CEIS Health Report 2006 For day hos
Page 93 and 94: CEIS Health Report 2006 There is co
Page 95 and 96: CEIS Health Report 2006 1.6 - The r
Page 97 and 98: CEIS Health Report 2006 the Primary
Page 99 and 100: CEIS Health Report 2006 Table 1 - T
Page 101 and 102: CEIS Health Report 2006 • “phys
Page 103 and 104: CEIS Health Report 2006 1.7 - Evolu
Page 105 and 106:
CEIS Health Report 2006 As can be o
Page 107 and 108:
CEIS Health Report 2006 Another int
Page 109 and 110:
CEIS Health Report 2006 Some signif
Page 111 and 112:
CEIS Health Report 2006 1.7.5 Concl
Page 113 and 114:
CEIS Health Report 2006 [114]
Page 116:
Introduction Public deficit in the
Page 119 and 120:
CEIS Health Report 2006 The cumulat
Page 121 and 122:
CEIS Health Report 2006 tegies of i
Page 123 and 124:
CEIS Health Report 2006 gest that t
Page 125 and 126:
CEIS Health Report 2006 increase of
Page 127 and 128:
CEIS Health Report 2006 increase in
Page 129 and 130:
CEIS Health Report 2006 [130]
Page 131 and 132:
CEIS Health Report 2006 It is also
Page 133 and 134:
CEIS Health Report 2006 shifting be
Page 135 and 136:
CEIS Health Report 2006 year (AIHW
Page 137 and 138:
CEIS Health Report 2006 cost of the
Page 139 and 140:
CEIS Health Report 2006 The Second
Page 141 and 142:
CEIS Health Report 2006 2.5 - Imple
Page 143 and 144:
CEIS Health Report 2006 2.5.3 Shift
Page 145 and 146:
CEIS Health Report 2006 Table 1 - P
Page 147 and 148:
CEIS Health Report 2006 and, conseq
Page 149 and 150:
CEIS Health Report 2006 Grant whose
Page 151 and 152:
CEIS Health Report 2006 Generally s
Page 153 and 154:
CEIS Health Report 2006 Scheme for
Page 156 and 157:
3.1 - The efficiency of Regional He
Page 158 and 159:
Table 2 - LEA Financing REGIONS HOS
Page 160 and 161:
• Campania, with strong financial
Page 162 and 163:
[163] CEIS Health Report 2006
Page 164 and 165:
hospital stays has reduced the aver
Page 166 and 167:
treated varies greatly. The highest
Page 168 and 169:
CMS = f(COST, CMP, PL, RC, DM , PME
Page 170 and 171:
formance, implying an increase in a
Page 172 and 173:
3.3 - The National Health System Ev
Page 174 and 175:
3.3.3 Cooperation with the Regional
Page 176 and 177:
the contract conditions are previou
Page 178 and 179:
Consequentially, in order to avoid
Page 180 and 181:
order through the MEPA) numbered 14
Page 182 and 183:
3.4 - Strengthening the capacity fo
Page 184 and 185:
for designing and governing organiz
Page 186 and 187:
the hierarchical and management rol
Page 188 and 189:
tions may appear and disappear, the
Page 190 and 191:
lop, rather than a variable to be c
Page 192 and 193:
units along business lines were unq
Page 194 and 195:
cooperation to achieve the developm
Page 196 and 197:
However, to manage a multi-site hos
Page 198 and 199:
Figure 2 - AVS Strategy map • con
Page 200 and 201:
cialties, but what sets them apart,
Page 202 and 203:
nistically or quantitatively. Hence
Page 204 and 205:
portant for healthcare industry, as
Page 206 and 207:
tor is that General Managers usuall
Page 208 and 209:
cation of the ABC and, in general,
Page 210 and 211:
● Kaplan R, Norton D (1992), “T
Page 212 and 213:
3.7 - The management of healthcare
Page 214 and 215:
Table 1 - Pathway for st elevated a
Page 216 and 217:
[217] CEIS Health Report 2006 Table
Page 218 and 219:
Vaginal childbirth Some synthesis i
Page 220 and 221:
Politiche sanitarie, marzo-aprile.
Page 222 and 223:
dental work, the purchase or rental
Page 224 and 225:
2. We might suppose that the state
Page 226:
● OECD (2004), “Towards High -
Page 230 and 231:
4.1 - Equity in the italian healthc
Page 232 and 233:
Table 2 - Association indexes betwe
Page 234 and 235:
4.1.5 Structure of health expenditu
Page 236 and 237:
Table 9 - Regional distribution of
Page 238 and 239:
strophic payments; moreover, the se
Page 240:
● Doglia M, Spandonaro F, “Il p
Page 243 and 244:
CEIS Health Report 2006 (i represen
Page 245 and 246:
CEIS Health Report 2006 sence of di
Page 247 and 248:
CEIS Health Report 2006 -0,0030, wh
Page 249 and 250:
CEIS Health Report 2006 Although co
Page 252 and 253:
5.1 - The median age at death for m
Page 254 and 255:
causes and the median age at genera
Page 256 and 257:
in the South and Islands, not only
Page 258 and 259:
5.2 - Analysis of avoidable deaths
Page 260 and 261:
population of Italian citizens acco
Page 262 and 263:
We wish to underline the mortality
Page 264 and 265:
Diagram 4 - % composition of years
Page 266 and 267:
5.2.4 Comments The results of the a
Page 268 and 269:
among whites and blacks,1979-1989
Page 270 and 271:
Figure 1 - Division % of the quota
Page 272 and 273:
Figure 3 - Pharmaceutics expenditur
Page 274 and 275:
Table 3 - Gross fixed investments i
Page 276 and 277:
Table 4 - Share of medical device w
Page 278 and 279:
age dimension of enterprises (90 em
Page 280 and 281:
BOX 2: National Medical Device Clas
Page 282 and 283:
maceutiche in Italia (1997-2001)”
Page 284 and 285:
5.4 - Mobility of italian patients
Page 286 and 287:
Authority (ASL) will be charged for
Page 288 and 289:
43.950.716,00. At this stage, if yo
Page 290 and 291:
esting data are certainly provided
Page 292 and 293:
have carried out economic and stati
Page 294 and 295:
[295] CEIS Health Report 2006
Page 296 and 297:
✔ DE POUVOURVILLE GÉRARD Researc
Page 298 and 299:
✔ MENNINI FRANCESCO SAVERIO Degre
Page 300:
✔ SCHWEIGER ARTURO Health Economi
show all

Chapter 2

Create successful ePaper yourself

Delete template?

Save as template?